Our team published a retrospective analysis on ResearchGate that looks at how 3D mechanism-of-action (MoA) animation relates to funding outcomes in life sciences.
We screened 98 projects and evaluated 44 verified biotech, medtech, and academic cases (2020–2026) to determine the measurable business impact of 3D Mechanism-of-Action (MoA) animations.
Here are the key takeaways from the analysis:
– 3D scientific animation functions as a high-impact strategic driver – not just a design element. It directly bridges the “translational gap” for investors and grant committees.
– Reducing cognitive load speeds up technical due diligence, Â optimizes corporate valuation, and serves as a proven catalyst for multi-million-dollar rounds – from Pre-Seed up to Series D.Â
– Success was evident at every phase: from early-stage startups closing Seed rounds to late-stage companies securing landmark Big Pharma partnerships.
